Literature DB >> 16971624

Acute vertebral compression fractures in patients with multiple myeloma: evaluation of vertebral body edema patterns on MR imaging and the implications for vertebroplasty.

K F Layton1, K R Thielen, H J Cloft, D F Kallmes.   

Abstract

The presence of edema on MR imaging is a common finding in acute or subacute vertebral body compression fractures. Compression fractures can present in patients with benign osteoporosis, metastases, multiple myeloma, or hemangiomas. We present 2 patients with multiple myeloma who had symptomatic acute and subacute compression fractures documented on imaging studies without associated edema on MR imaging evaluation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971624      PMCID: PMC8139782     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

Review 1.  Percutaneous vertebroplasty.

Authors:  David F Kallmes; Mary E Jensen
Journal:  Radiology       Date:  2003-10       Impact factor: 11.105

2.  Age of fracture and clinical outcomes of percutaneous vertebroplasty.

Authors:  T J Kaufmann; M E Jensen; P A Schweickert; W F Marx; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

3.  Correlation between preprocedural MRI findings and clinical outcomes in the treatment of chronic symptomatic vertebral compression fractures with percutaneous vertebroplasty.

Authors:  Daniel B Brown; Craig B Glaiberman; Louis A Gilula; Joshua S Shimony
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

4.  Successful treatment of a chronic post-traumatic 5-year-old osteoporotic vertebral compression fracture by percutaneous vertebroplasty.

Authors:  F G Irani; J P Morales; T Sabharwal; R Dourado; A Gangi; A Adam
Journal:  Br J Radiol       Date:  2005-03       Impact factor: 3.039

5.  Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects.

Authors:  M E Jensen; A J Evans; J M Mathis; D F Kallmes; H J Cloft; J E Dion
Journal:  AJNR Am J Neuroradiol       Date:  1997 Nov-Dec       Impact factor: 3.825

Review 6.  Percutaneous vertebroplasty in the treatment of osteoporotic compression fractures.

Authors:  M E Jensen; J E Dion
Journal:  Neuroimaging Clin N Am       Date:  2000-08       Impact factor: 2.264

7.  Predictors of outcomes of percutaneous vertebroplasty for osteoporotic vertebral fractures.

Authors:  Luis Alvarez; Antonio Pérez-Higueras; Juan J Granizo; Ignacio de Miguel; Diana Quiñones; Roberto E Rossi
Journal:  Spine (Phila Pa 1976)       Date:  2005-01-01       Impact factor: 3.468

  7 in total
  6 in total

1.  Effect of Systemic Therapies on Outcomes following Vertebroplasty among Patients with Multiple Myeloma.

Authors:  R J McDonald; J S McDonald; D F Kallmes; V T Lehman; F E Diehn; J T Wald; K R Thielen; A Dispenzieri; P H Luetmer
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-06       Impact factor: 3.825

2.  Vertebroplasty in multiple myeloma: outcomes in a large patient series.

Authors:  R J McDonald; A T Trout; L A Gray; A Dispenzieri; K R Thielen; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

Review 3.  [Cement injection for spinal metastases (vertebroplasty and kyphoplasty)].

Authors:  P F Heini; S Pfäffli
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

4.  Percutaneous vertebroplasty: a first line treatment in traumatic non-osteoporotic vertebral compression fractures.

Authors:  Hossam Elnoamany
Journal:  Asian Spine J       Date:  2015-04-15

5.  Malignant myeloma in a patient after treatment for osteoporosis with teriparatide; a rare coincidence.

Authors:  Terje Forslund; Anna-Mari Koski; Arvo Koistinen; Anu Sikiö
Journal:  Clin Med Case Rep       Date:  2008-08-29

6.  Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study.

Authors:  D Anitha; Thomas Baum; Jan S Kirschke; Karupppasamy Subburaj
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.